Because SARS-CoV-2 nucleocapsid (N) antibodies are not generated by mRNA vaccines targeted to the S protein, this can be used as a proxy for SARS-CoV-2 infection35, with recognized limitations36. Here, PROS1 is linked to COVID-19.